Nature CommunicationsMicrobiologyPeer-reviewed journal article
A Type VII-secreted toxin enables inter-mycobacterial competition
Samuel T. BenedictiD, Kieran BowraniD, E K Lee, Jean‐Lou ReyreiD, Huda AhmadiD, Aaron FrankliniD, Nicole MietrachiD, Cheng-Ruei Han, Jia Mun ChaniD, Abigail J. LaytoniD, Emmanuele SeveriiD, Eleanor BoardmaniD, Kamilla AnochshenkoiD, Gregory Goudge, Simon G. CaultoniD, Todd L. LowaryiD, Andrew L. LoveringiD, Manuel BanzhafiD, Elisabeth C. LoweiD, Tracy PalmeriD, Patrick Joseph MoynihaniD
Abstract
Summary ParagraphMost bacteria live in complex environments where resources are scarce and competition is fierce. These organisms have evolved mechanisms to compete with other bacteria, often through the specialised secretion of proteinaceous toxins. Mycobacteria have not previously been reported to engage in this form of competition. The thick and unusual cell wall of mycobacteria, comprised of peptidoglycan, arabinogalactan and mycolic acids, is generally thought to be highly protective to these bacteria. Many enzymes have evolved to maintain this structure, including the GH183 family, which cleaves arabinogalactan. Here, we establish for the first time that some mycobacteria have weaponised a subset of these endo-D-arabinanases to enable inter-bacterial competition. We show that mycobacteria secrete an endo-D-arabinanase effector via the type VII secretion system that specifically targets the arabinogalactan layer of the Mycobacteriales cell envelope. Using structural biology and biochemistry, we identify the molecular basis for this activity and reveal a new protein family that protects the bacterium from the activity of this toxin. Finally, our data uncover widespread T7-secreted toxins in the Mycobacteriales, pointing to extensive inter-mycobacterial competition.
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: biophysical modeling
- Citations
- 1
- FWCI
- 4.94
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterizing the interaction of a type VII-secreted antimycobacterial toxin with its small helical partner proteins
Eunice Lee, Kieran Bowran, … Tracy Palmer·bioRxiv·Aug 25, 2026
- The Type VI Secretion System of the Emerging Pathogen Stenotrophomonas maltophilia has Antibacterial Properties
C. Crisan, D. Van Tyne, J. B. Goldberg·bioRxiv·May 30, 2023
- Pseudomonas aeruginosa deploys competitor-specific antagonistic strategies
Ziyang Chen, Ned S. Wingreen, Zemer Gitai·bioRxiv·Apr 17, 2026
- Cell wall proteomics in live Mycobacterium tuberculosis uncovers exposure of ESX substrates to the periplasm
N. Jaisinghani, M. L. Previti, … J. C. Seeliger·bioRxiv·Mar 29, 2023
- Mining the human gut microbiome identifies mycobacterial D-arabinan degrading enzymes
O. Al-Jourani, S. T. Benedict, … P. J. Moynihan·bioRxiv·Jul 22, 2022
- Staphylococcal secreted cytotoxins are competition sensing signals for Pseudomonas aeruginosa
G. Z. Wang, E. A. Warren, … D. H. Limoli·bioRxiv·Jan 29, 2023